In this IRB-approved, HIPAA-compliant retrospective study, 63 consecutive women with newly diagnosed breast cancer undergoing neoadjuvant chemotherapy with pre- and post- chemotherapy breast MRI on a 3.0 Tesla scanner prior to surgery at our institution between January 2013 and December 2015 were included for analysis. Decrease in tumor size, decrease in peak enhancement, increase in time to peak, decrease in wash in, and decrease in wash out on post-chemotherapy breast MRIs were predictive of pathologic complete response on surgical pathology, a surrogate for prognosis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords